125 related articles for article (PubMed ID: 11314048)
1. Modulation of phospholipase D by hexadecylphosphorylcholine: a putative novel mechanism for its antitumoral activity.
Lucas L; Hernández-Alcoceba R; Penalva V; Lacal JC
Oncogene; 2001 Mar; 20(9):1110-7. PubMed ID: 11314048
[TBL] [Abstract][Full Text] [Related]
2. The antitumor phospholipid analog, hexadecylphosphocholine, activates cellular phospholipase D.
Wieder T; Zhang Z; Geilen CC; Orfanos CE; Giuliano AE; Cabot MC
Cancer Lett; 1996 Feb; 100(1-2):71-9. PubMed ID: 8620456
[TBL] [Abstract][Full Text] [Related]
3. Sphingosylphosphorylcholine generates reactive oxygen species through calcium-, protein kinase Cdelta- and phospholipase D-dependent pathways.
Jeon ES; Kang YJ; Song HY; Im DS; Kim HS; Ryu SH; Kim YK; Kim JH
Cell Signal; 2005 Jun; 17(6):777-87. PubMed ID: 15722202
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase D-mediated hydrolysis of phosphatidylcholine: role in cell signalling.
Liscovitch M; Ben-Av P; Danin M; Faiman G; Eldar H; Livneh E
J Lipid Mediat; 1993 Nov; 8(3):177-82. PubMed ID: 8268464
[TBL] [Abstract][Full Text] [Related]
5. Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells.
Neri LM; Bortul R; Borgatti P; Tabellini G; Baldini G; Capitani S; Martelli AM
Mol Biol Cell; 2002 Mar; 13(3):947-64. PubMed ID: 11907274
[TBL] [Abstract][Full Text] [Related]
6. Choline kinase inhibitors as a novel approach for antiproliferative drug design.
Hernández-Alcoceba R; Saniger L; Campos J; Núñez MC; Khaless F; Gallo MA; Espinosa A; Lacal JC
Oncogene; 1997 Nov; 15(19):2289-301. PubMed ID: 9393874
[TBL] [Abstract][Full Text] [Related]
7. Ral and Rho-dependent activation of phospholipase D in v-Raf-transformed cells.
Frankel P; Ramos M; Flom J; Bychenok S; Joseph T; Kerkhoff E; Rapp UR; Feig LA; Foster DA
Biochem Biophys Res Commun; 1999 Feb; 255(2):502-7. PubMed ID: 10049738
[TBL] [Abstract][Full Text] [Related]
8. Role of Src kinase in diperoxovanadate-mediated activation of phospholipase D in endothelial cells.
Parinandi NL; Roy S; Shi S; Cummings RJ; Morris AJ; Garcia JG; Natarajan V
Arch Biochem Biophys; 2001 Dec; 396(2):231-43. PubMed ID: 11747302
[TBL] [Abstract][Full Text] [Related]
9. Calcium and protein kinase C (PKC)-related kinase mediate alpha 1A-adrenergic receptor-stimulated activation of phospholipase D in rat-1 cells, independent of PKC.
Parmentier JH; Ahmed A; Ruan Y; Gandhi GK; Saeed AE; Malik KU
J Pharmacol Exp Ther; 2002 Dec; 303(3):1206-15. PubMed ID: 12438545
[TBL] [Abstract][Full Text] [Related]
10. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of human hematopoietic progenitor cells by the alkylphosphocholines hexadecylphosphocholine and hexadecyl-N,N,N-trimethyl-hexanolamine.
Ergezinger K; Vehmeyer K; Unger C
Anticancer Res; 1999; 19(4B):3213-9. PubMed ID: 10652614
[TBL] [Abstract][Full Text] [Related]
12. Role of phospholipase D signaling in ethanol-induced inhibition of carbachol-stimulated DNA synthesis of 1321N1 astrocytoma cells.
Guizzetti M; Thompson BD; Kim Y; VanDeMark K; Costa LG
J Neurochem; 2004 Aug; 90(3):646-53. PubMed ID: 15255942
[TBL] [Abstract][Full Text] [Related]
13. Hexadecylphosphocholine inhibits phosphatidylinositol and phosphatidylcholine phospholipase C in human leukemia cells.
Berkovic D; Goeckenjan M; Lüders S; Hiddemann W; Fleer EA
J Exp Ther Oncol; 1996 Sep; 1(5):302-11. PubMed ID: 9414418
[TBL] [Abstract][Full Text] [Related]
14. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity.
Uberall F; Oberhuber H; Maly K; Zaknun J; Demuth L; Grunicke HH
Cancer Res; 1991 Feb; 51(3):807-12. PubMed ID: 1846318
[TBL] [Abstract][Full Text] [Related]
15. Hexadecylphosphocholine inhibits invasion of mouse T-cell lymphoma cells in two different invasion assays.
Schaider H; Seidl H; Berger MR; Hofmann-Wellenhof R; Tritthart HA; Smolle J
Anticancer Res; 1998; 18(2A):995-8. PubMed ID: 9615753
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase D overcomes cell cycle arrest induced by high-intensity Raf signaling.
Joseph T; Bryant A; Frankel P; Wooden R; Kerkhoff E; Rapp UR; Foster DA
Oncogene; 2002 May; 21(22):3651-8. PubMed ID: 12032867
[TBL] [Abstract][Full Text] [Related]
17. Phospholipase D in platelets and other cells.
Vorland M; Thorsen VA; Holmsen H
Platelets; 2008 Dec; 19(8):582-94. PubMed ID: 19012176
[TBL] [Abstract][Full Text] [Related]
18. Distinct signaling pathways mediate cardiomyocyte phospholipase D stimulation by endothelin-1 and thrombin.
Fahimi-Vahid M; Gosau N; Michalek C; Han L; Jakobs KH; Schmidt M; Roberts N; Avkiran M; Wieland T
J Mol Cell Cardiol; 2002 Apr; 34(4):441-53. PubMed ID: 11991733
[TBL] [Abstract][Full Text] [Related]
19. Interference of new alkylphospholipid analogues with mitogenic signal transduction.
Maly K; Uberall F; Schubert C; Kindler E; Stekar J; Brachwitz H; Grunicke HH
Anticancer Drug Des; 1995 Jul; 10(5):411-25. PubMed ID: 7639930
[TBL] [Abstract][Full Text] [Related]
20. Signalling components involved in the coupling of alpha 1-adrenoceptors to phospholipase D in neonatal rat cardiac myocytes.
Gosau N; Fahimi-Vahid M; Michalek C; Schmidt M; Wieland T
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):468-76. PubMed ID: 12070761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
